As of 2025-07-14, the Intrinsic Value of Allovir Inc (ALVR) is -95.45 USD. This Allovir valuation is based on the model Peter Lynch Fair Value. With the current market price of 9.81 USD, the upside of Allovir Inc is -1,072.96%.
Based on its market price of 9.81 USD and our intrinsic valuation, Allovir Inc (ALVR) is overvalued by 1,072.96%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -95.45 - -95.45 | -95.45 | -1,072.96% |
| P/E | (271.07) - (511.60) | (415.20) | -4332.4% |
| DDM - Stable | (81.81) - (226.48) | (154.14) | -1671.3% |
| DDM - Multi | (193.94) - (460.92) | (277.76) | -2931.4% |
| Market Cap (mil) | 30.20 |
| Beta | -0.56 |
| Outstanding shares (mil) | 3.08 |
| Enterprise Value (mil) | -88.09 |
| Market risk premium | 4.60% |
| Cost of Equity | 15.96% |
| Cost of Debt | 5.00% |
| WACC | 10.48% |